Credit Suisse Reiterates Outperform on Acadia Healthcare Co, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst A.J. Rice has reiterated an 'Outperform' rating on Acadia Healthcare Co (NASDAQ:ACHC) and maintained a $95 price target.

July 31, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acadia Healthcare Co's stock rating has been reiterated as 'Outperform' by Credit Suisse, with a maintained price target of $95.
The reiteration of an 'Outperform' rating by a major financial institution like Credit Suisse is a positive signal for Acadia Healthcare Co. The maintained price target of $95 also indicates confidence in the company's performance, which could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100